BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11204938)

  • 21. A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment.
    Obel EB; Munk-Jensen N; Svenstrup B; Bennett P; Micic S; Henrik-Nielsen R; Nielsen SP; Gydesen H; Jensen BM
    Maturitas; 1993 Jan; 16(1):13-21. PubMed ID: 8429800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women.
    Sturdee DW; Archer DF; Rakov V; Lang E;
    Climacteric; 2008 Feb; 11(1):63-73. PubMed ID: 18202966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow.
    Fernandes CE; Pompei LM; Machado RB; Ferreira JA; Melo NR; Peixoto S
    Maturitas; 2008 Mar; 59(3):249-58. PubMed ID: 18359175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy.
    Stadberg E; Mattsson LA; Uvebrant M
    Maturitas; 1996 Feb; 23(1):31-9. PubMed ID: 8861084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of standard and low dose 17beta-estradiol plus norethisterone acetate on body composition and leptin in postmenopausal women at risk of body mass index and waist girth related cardiovascular and metabolic disease.
    Odabasi AR; Yuksel H; Karul A; Kozaci D; Sezer SD; Onur E
    Saudi Med J; 2007 Jun; 28(6):855-61. PubMed ID: 17530099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
    Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
    Stuedal A; Ma H; Bjørndal H; Ursin G
    Climacteric; 2009 Jun; 12(3):248-58. PubMed ID: 19387884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic studies of norethisterone-3-oxime and norethisterone-3-oxime acetate in rhesus monkey.
    Li DZ; Fu GM; Zuo MD; Zhou MY; Zhao XL; Wang GP; Wei ZN
    J Tongji Med Univ; 1991; 11(2):81-7. PubMed ID: 1816419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives.
    Fels H; Steward R; Melamed A; Granat A; Stanczyk FZ; Mishell DR
    Contraception; 2013 Jun; 87(6):732-7. PubMed ID: 23352800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women.
    Laivuori H; Koistinen HA; Karonen SL; Cacciatore B; Ylikorkala O
    Hum Reprod; 2001 Aug; 16(8):1632-5. PubMed ID: 11473954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic impact of tibolone compared with continuous-combined hormone replacement therapy. In the management of postmenopausal women with climacteric symptoms in the UK.
    Plumb JM; Guest JF
    Pharmacoeconomics; 2000 Nov; 18(5):477-86. PubMed ID: 11151401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antigonadotropic activity of progestins (19-nortestosterone and 19-norprogesterone derivatives) is not mediated through the androgen receptor.
    Couzinet B; Young J; Brailly S; Chanson P; Thomas JL; Schaison G
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4218-23. PubMed ID: 8954018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of hormone therapy and raloxifene on serum matrix metalloproteinase-2 and -9 in postmenopausal women.
    Christodoulakos GE; Panoulis CP; Lambrinoudaki IV; Botsis DS; Dendrinos SG; Economou E; Creatsas GC
    Menopause; 2004; 11(3):299-305. PubMed ID: 15167309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
    Georgiev DB; Manassiev NA
    Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
    Greenwald MW; Gluck OS; Lang E; Rakov V
    Menopause; 2005; 12(6):741-8. PubMed ID: 16278618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial.
    Garnero P; Jamin C; Benhamou CL; Pelissier C; Roux C
    Hum Reprod; 2002 Oct; 17(10):2748-53. PubMed ID: 12351557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.
    Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C
    Arzneimittelforschung; 1996 Aug; 46(8):766-73. PubMed ID: 9125276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.